Key points from article :
Mounjaro, a diabetes drug, is now approved for weight management in the UK.
This exciting development offers new hope for obese and overweight individuals struggling to lose weight.
Mounjaro works by reducing appetite and cravings, leading to significant weight loss in clinical trials.
Studies have shown an average weight loss of 13.4% to 22.5% with weekly injections of tirzepatide, the active ingredient in Mounjaro.
While some side effects, such as nausea, diarrhoea, and constipation, may occur, Mounjaro should be used with a reduced-calorie diet and increased exercise for optimal results.
This groundbreaking approval opens up new possibilities for effective weight management, potentially transforming the lives of many individuals.
